Diving into the complex world of microbiome research, I had the privilege of speaking with Ivan Kairatov, a renowned biopharma expert with extensive experience in technology and innovation within the industry. With a strong background in research and development, Ivan has been instrumental in
Ivan Kairatov has spent years at the crossroads of oncology and drug development, translating trial signals into day-to-day decisions for patients with localized prostate cancer. In this conversation, he unpacks new evidence showing that most of the value from androgen deprivation therapy (ADT)
Imagine a world where a lung cancer diagnosis no longer feels like a death sentence, but rather a challenge that can be managed with the right tools and support. For too long, this disease has carried a heavy burden of fear and stigma, often seen as an unstoppable force due to its high mortality
Watching a single enzyme switch from a standstill to full sprint while decoding DNA inside a mammalian cell would have sounded like science fiction not long ago, yet that leap just became a measurable reality thanks to a single-molecule transcription platform that links factor binding to RNA
Rising demand, tighter budgets, and complex patients have pushed cardiovascular imaging from supporting act to central protagonist, and that shift is on full display in Vienna as echo, CMR, CT, and nuclear cardiology share one stage from December 11–13. Congress organizers set a clear purpose:
Ivan Kairatov has spent years at the intersection of structural biology and biopharma, translating difficult, dynamic molecules into practical insights that can power new therapeutics. In this conversation, he unpacks a “molecular film” of a self-splicing ribozyme—captured almost frame by frame—and
In operating rooms where silence often amplifies stress, a small change—a pair of headphones and a vigilant recovery plan—can shift the arc of the first hours after colorectal cancer surgery, easing the path from anesthesia to wakefulness while trimming complications that make families and
Chronic HIV infection, even under suppressive antiretroviral therapy, can trap the immune system in a state of simmering alarm that never fully resolves and quietly erodes the fitness of the very T cells needed for durable control of the virus. That conundrum has intensified attention on the small
In emergency rooms, prenatal clinics, and primary care offices alike, clinicians reach for ultrasound because it delivers immediate answers without exposing patients to ionizing radiation, yet it still runs through the same radiology workflows that govern X-rays and CT. That dual identity raises a
In an era where supply chain resilience and access to life-saving therapies dominate healthcare discussions, AstraZeneca's announcement of a $2 billion investment in Maryland facilities has captured significant attention, raising critical questions about domestic production. This ambitious
